Piper Sandler Starts MiniMed Group (MMED) at Neutral
Piper Sandler analyst Matt O\'Brien initiates coverage on MiniMed Group (NASDAQ: MMED) with a Neutral rating and a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)